Mongolia vs Niger: The number of people with susceptibility test result for rifampicin
Mongolia
1,106
in 2021
Niger
1,127
in 2021
Mongolia rank
64th
Niger rank
63rd
The number of people with susceptibility test result for rifampicin over time
- Mongolia
- Niger
How they compare
Niger currently reports 1,127 against 1,106 in Mongolia, a difference of 21.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Mongolia ahead.
Mongolia ranks 64th and Niger ranks 63rd of 155 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Mongolia | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,235 | 153 | 1,082 | Mongolia |
| 2020s | 1,359 | 965.5 | 393.5 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Mongolia or Niger?
- Niger, at 1,127 against 1,106 in Mongolia as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Mongolia and Niger?
- 21, with Niger ahead.
- How many years of comparable data are there for Mongolia and Niger?
- 5 years are reported by both, from 2017 to 2021.
- How do Mongolia and Niger rank globally for the number of people with susceptibility test result for rifampicin?
- Mongolia ranks 64th and Niger ranks 63rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.